NCT02277600View on ClinicalTrials.gov

A Phase 1 Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 5, 2014

Primary Completion Date

January 12, 2015

Study Completion Date

January 12, 2015

Conditions
Infection, Human Immunodeficiency Virus
Interventions
DRUG

BMS-663068

BMS-663068

DRUG

Darunavir

Darunavir

DRUG

Cobicistat

Cobicistat

Trial Locations (1)

78209

GSK Investigational Site, San Antonio

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY